Qubit Pharmaceuticals
FranceEntry
2022
Hold
4yr
Status
Active
Who owns Qubit Pharmaceuticals?
Qubit Pharmaceuticals is currently owned by XAnge through XAnge 04 (2021 vintage), since 2022. Across its history, Qubit Pharmaceuticals has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Key takeaways
- ·Co-held by Audacia, Quantonation Ventures, Omnes Capital and XAnge since 2020.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 4 holders · 2020 · present
AudaciaActive
2020 · present(6yr) · Quantonation I · 2018 · VC
Quantonation VenturesActive
2020 · present(6yr) · Quantonation I · 2019 · VC
XAngeActive
2022 · present(4yr) · XAnge 04 · 2021 · VC
Omnes CapitalActive
2022 · present(4yr) · Omnes Real Tech 1 · 2018 · VC
More from XAnge 04
Other portfolio companies in the same fund.
Germany
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Qubit Pharmaceuticals
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Qubit Pharmaceuticals?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Qubit Pharmaceuticals.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue